"Antineoplastic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Descriptor ID |
D000970
|
MeSH Number(s) |
D27.505.954.248
|
Concept/Terms |
Antineoplastic Agents- Antineoplastic Agents
- Agents, Antineoplastic
- Antineoplastic Drugs
- Drugs, Antineoplastic
- Antineoplastics
- Chemotherapeutic Anticancer Drug
- Drug, Chemotherapeutic Anticancer
- Antitumor Drugs
- Drugs, Antitumor
- Cancer Chemotherapy Agents
- Agents, Cancer Chemotherapy
- Chemotherapy Agents, Cancer
- Cancer Chemotherapy Drugs
- Chemotherapy Drugs, Cancer
- Drugs, Cancer Chemotherapy
- Chemotherapeutic Anticancer Agents
- Agents, Chemotherapeutic Anticancer
- Anticancer Agents
- Agents, Anticancer
- Antitumor Agents
- Agents, Antitumor
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Agents".
This graph shows the total number of publications written about "Antineoplastic Agents" by people in this website by year, and whether "Antineoplastic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1997 | 3 | 1 | 4 |
1999 | 3 | 1 | 4 |
2000 | 1 | 1 | 2 |
2001 | 2 | 0 | 2 |
2002 | 6 | 4 | 10 |
2003 | 2 | 2 | 4 |
2004 | 4 | 2 | 6 |
2005 | 7 | 1 | 8 |
2006 | 9 | 5 | 14 |
2007 | 8 | 3 | 11 |
2008 | 10 | 2 | 12 |
2009 | 16 | 5 | 21 |
2010 | 12 | 8 | 20 |
2011 | 14 | 9 | 23 |
2012 | 13 | 6 | 19 |
2013 | 23 | 8 | 31 |
2014 | 19 | 7 | 26 |
2015 | 28 | 8 | 36 |
2016 | 32 | 8 | 40 |
2017 | 22 | 7 | 29 |
2018 | 24 | 8 | 32 |
2019 | 18 | 6 | 24 |
2020 | 20 | 6 | 26 |
2021 | 18 | 6 | 24 |
2022 | 8 | 0 | 8 |
2023 | 6 | 0 | 6 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antineoplastic Agents" by people in Profiles.
-
Cardiovascular toxicities associated with bispecific T-cell engager therapy. J Immunother Cancer. 2024 Feb 21; 12(2).
-
Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer. Colloids Surf B Biointerfaces. 2024 Jan; 233:113631.
-
The emerging use of antibody-drug conjugates in ovarian cancer. Clin Adv Hematol Oncol. 2023 05; 21(5):244-246.
-
The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases. Drug Resist Updat. 2023 May; 68:100958.
-
Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Lett. 2023 04 01; 558:216093.
-
CopA3 peptide inhibits MDM2-p53 complex stability in colorectal cancers and activates p53 mediated cell death machinery. Life Sci. 2023 Apr 01; 318:121476.
-
Carbohydrate-Small Molecule Hybrids as Lead Compounds Targeting IL-6 Signaling. Molecules. 2023 Jan 09; 28(2).
-
Advances in antibody-drug conjugates for gynecologic malignancies. Curr Opin Obstet Gynecol. 2023 02 01; 35(1):6-14.
-
Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor. BMC Med. 2022 08 24; 20(1):257.
-
Halogenated Flavonoid Derivatives Display Antiangiogenic Activity. Molecules. 2022 Jul 25; 27(15).